与SARS-CoV-2 -IgG血清状态相关的代谢学概况作为一种替代诊断方法
Mariam M Al Eissa1, Reem H AlMalki2, Randh Alahmari3
1College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Public Health Lab, Public Health Authority, Riyadh, Saudi Arabia; King Khaled Eye Specialist Hospital (KKESH) Research Centre, Riyadh, Kingdom of Saudi Arabia; Computational Sciences Department at the Centre for Genomic Medicine (CGM), King Faisal Specialist Hospital & Research Center, Riyadh, Kingdom of Saudi Arabia.
Journal of infection and public health
|February 19, 2026
概括
这项研究确定了SARS-CoV-2感染个体的显著代谢变化,揭示了COVID-19诊断和免疫反应见解的潜在生物标志物. 这些COVID-19宿主免疫相互作用发现需要进一步验证.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
背景情况:
- 由于宿主反应不同,COVID-19大流行需要改进诊断和治疗方法.
- 未定位的代谢学可以揭示与SARS-CoV-2感染中的免疫变异相关的分子变化.
研究的目的:
- 在有或没有SARS-CoV-2感染的个体中识别不同的代谢概况.
- 为了发现COVID-19检测和监测的潜在代谢生物标志物.
主要方法:
- 通过SARS-CoV-2IgG状态分层的49个人的横截面观测研究.
- 基于LC/MS的非向代谢分析.
- 进行了多变量统计,分子注释,途径和网络分析.
主要成果:
- 在IgG阳性和IgG阴性组之间,有319个代谢物的调节失调 (218个上升,101个下降).
- 4 - 基斯芬甘氨酸和甘胺GM1显示出高的诊断潜力 (AUC为0.883-0.95).
- 关键受影响的途径包括乌比奎农,氨酸,皮里米丁和谷氨代谢,影响脂质代谢和免疫信号.
结论:
- 代谢变化与SARS-CoV-2感染有关,提供了对宿主免疫相互作用的见解.
- 已识别的代谢物参与脂质代谢,免疫反应和炎症.
- 结果需要在更大的队列中验证,以告知未来的COVID-19研究和治疗策略.
相关概念视频
02:50Conjugated Proteins
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.